Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Revance Therapeutics Inc (NASDAQ:RVNC)

16.79
Delayed Data
As of 9:40am ET
 -0.06 / -0.36%
Today’s Change
12.54
Today|||52-Week Range
42.41
-50.85%
Year-to-Date
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close16.85
Today’s open16.87
Day’s range16.75 - 16.96
Volume3,091
Average volume (3 months)287,404
Market cap$480.0M
Dividend yield--
Data as of 9:40am ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+6.79%
Earnings growth (this year)-15.63%
Earnings growth (next 5 years)--
Revenue growth (last year)-21.67%
P/E ratioNM
Price/Sales2,771.57
Price/Book1.88

Competitors

 Today’s
change
Today’s
% change
NERVMinerva Neuroscience...-0.03-0.21%
OMEROmeros Corp-0.01-0.09%
LBIOLion Biotechnologies...0.000.00%
CYNACynapsus Therapeutic...+0.02+0.05%
Data as of 10:02am ET, 09/28/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.89
Annual revenue (last year)$300.0K
Annual profit (last year)-$73.5M
Net profit margin-24,492.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
L. Daniel Browne
Chief Operating Officer
Abhay Joshi
Corporate headquarters
Newark, California

Forecasts

Search for Jobs